Document is current
Any future updates will be listed below
-
Authors
Zhou, Qi
Wang, Junyu
Cheng, Ke
Mei, Ruyi
Heegsma, Janette
Moshage, Han
Harmsen, Martin C.
Faber, Klaas Nico
Sun, Pingnan https://orcid.org/0000-0002-3325-8062
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Guangdong Province (2025A1515010366)
Natural Science Foundation of Guangdong Province (2023A1515010449)
CSC Global Foundation (202006250036 (J.W.))
- License Information
-
More Information
Article History
Received: 21 May 2025
Accepted: 13 November 2025
First Online: 27 November 2025
Declarations
:
: For UC-MSC experiments: (1) Title of the approved project: Histone phosphorylation-mediated mechanisms by which human umbilical cord mesenchymal stem cells alleviate sepsis-induced lung injury; (2) Name of the institutional approval committee or unit: The Ethics Committee of the Second Affiliated Hospital of Shantou University Medical College; (3) Approval number: No.2021-89; (4) Date of approval: 2021/07/26. For animal experiments: (1) Title of the approved project: A mechanistic investigation into the therapeutic potential of selectively regulating MMP2 and other pro-Angiogenic factors secreted by mesenchymal stem cells in liver fibrosis; (2) Name of the institutional approval committee or unit: The Experimental Animal Ethics Committee of Shantou University Medical College; (3) Approval number: SUMCXM2024-262; (4) Date of approval: 2024/07/12.
: All authors agreed on the final approval of the version to be published.
: The authors of this manuscript have no conflicts of interests.
